Retatrutide is still in clinical trials, so its full safety profile is not yet known
Further studies are needed to investigate this hypothesis, but we suspect recent changes in medication prescribing practices and medication prices will result in large datasets allowing scientists to investigate these potential relationships. Christine Rode Schwarz, PhD, of the Steno Diabetes Center in Copenhagen, and her co-authors pointed to this case in a commentary titled, Mechanism and Context: Making Sense of Adverse Events With GLP-1-based Therapy , also published in JCEM Case Reports later that year
Manufactured by Eli Lilly, retatrutide is still in phase III clinical trials
Retatrutide Dosage Guidelines Starting Dose The recommended starting doses for retatrutide vary across clinical trials and medical sources as researchers work to find optimal protocols
Interestingly, some trial participants reported improved sleep quality on retatrutide, possibly related to weight loss reducing sleep apnea symptoms
doi: 10.1038/s41514-022-00084-z